Nonprofit generic drug manufacturer Civica said it has updated its 340B pricing as it obtains baseline average manufacturer price (AMP) data from generic drug manufacturers that make the same products. | Marco Verch https://www.flickr.com/photos/30478819@N08/

Nonprofit Generic Drugmaker Civica Is Providing Refunds for 340B Overcharges

Civica, the nonprofit generic drug manufacturer that health systems created in response to drug shortages, owes 340B covered entities refunds for overcharges on 13 NDCs from April 13, 2020 through Feb. 23, 2021.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
×

Sign up for news summaries and alerts from 340B Report